da Silva Jorge Santos sold $2.0M of MoonLake Immunotherapeutics (MLTX)

Executed Jul 9, disclosed Jul 13, 4 days later.

Value, as filed

$2.0M

102,225 sh across 2 lots

Executed

Jul 9

the trade date, as filed

Disclosed

Jul 13

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

da Silva Jorge Santos Chief Executive Officer profile →

da Silva Jorge Santos (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $3.0M of MLTX (200,000 sh across 2 lots, as filed), executed Dec 8 2025.

The name

MLTX

MoonLake Immunotherapeutics MLTX · Healthcare · 18 filings in 24 months ticker →

Healthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by da Silva Jorge Santos in MLTX

MLTXSALE MoonLake Immunotherapeutics $957K
47,775 sh × $20.03
Exec Jul 1
Filed Jul 2 · 4:10 PM ET MLTXSALE MoonLake Immunotherapeutics $2.8M
150,000 sh across 2 lots
Exec Apr 10
Filed Apr 14 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics $3.0M
200,000 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET